Compare TTEC & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTEC | BDSX |
|---|---|---|
| Founded | 1982 | 2005 |
| Country | United States | United States |
| Employees | 69400 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.8M | 122.0M |
| IPO Year | 1996 | 2020 |
| Metric | TTEC | BDSX |
|---|---|---|
| Price | $2.45 | $15.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | N/A | ★ $32.50 |
| AVG Volume (30 Days) | ★ 643.6K | 75.8K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.80 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,509,171,000.00 | $88,499,000.00 |
| Revenue This Year | N/A | $25.26 |
| Revenue Next Year | $0.10 | $19.70 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 2.15 | ★ 24.08 |
| 52 Week Low | $1.98 | $0.25 |
| 52 Week High | $5.60 | $20.21 |
| Indicator | TTEC | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 45.37 | 52.35 |
| Support Level | $2.09 | $6.33 |
| Resistance Level | $3.91 | $20.21 |
| Average True Range (ATR) | 0.20 | 1.25 |
| MACD | -0.02 | -0.29 |
| Stochastic Oscillator | 20.61 | 42.96 |
TTEC Holdings Inc provides customer engagement management tools and services. The company operates through two operating segment, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its revenues are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.